Registry-listed formulations

levonorgestrel butanoate · mesh:C095485

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    1
    50%
    Phase 1
    1
    50%

    Phase Distribution

    1

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 1Safety & dosage
    1(50.0%)
    Phase 2Efficacy & side effects
    1(50.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Completed(1)

    Detailed Status

    Completed1
    Not yet recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 11 (50.0%)
    Phase 21 (50.0%)

    Trials by Status

    completed150%
    not_yet_recruiting150%

    Recent Activity

    Clinical Trials (2)

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2